Raymond James & Associates »

Cardiol Therapeutics Inc- foreign shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Cardiol Therapeutics Inc- foreign (CRDL) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Cardiol Therapeutics Inc- foreign

Tip: Access up to 7 years of quarterly data

All positions including Cardiol Therapeutics Inc- foreign held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardiol Therapeutics Inc- foreign by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $20k 11k 1.81
2023-12-31 $9.4k 11k 0.84

More positions owned by Raymond James & Associates

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Home Depot (HD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Usa Min Vol (USMV)
Merck & Co (MRK)
Eaton Corp SHS (ETN)

View all positions for Raymond James & Associates

Top funds holding Cardiol Therapeutics Inc- foreign

MMCAP International Inc. SPC
Tejara Capital
AXS Investments
Lion Street Advisors
Cambridge Investment Research Advisors
Bank Of Montreal
We Are One Seven
Credit Suisse
Advisor Group Holdings
Marble Harbor Investment Counsel
Royal Bank of Canada
Goldman Sachs Group
Two Sigma Advisers
Private Ocean
Citadel Advisors

View all funds holding Cardiol Therapeutics Inc- foreign